Proof-of-concept endoscopic study of naproxen (OXP 005)

Trial Profile

Proof-of-concept endoscopic study of naproxen (OXP 005)

Phase of Trial: Phase II

Latest Information Update: 10 Mar 2015

At a glance

  • Drugs Naproxen (Primary)
  • Indications Musculoskeletal pain
  • Focus Adverse reactions; Proof of concept
  • Sponsors Oxford Pharmascience
  • Most Recent Events

    • 10 Mar 2015 Title is not official; phase assumed; don't know if patients or volunteers.
    • 10 Mar 2015 New trial record
    • 05 Mar 2015 This study will be initiated after headline results have been reported from the phase I study (trial profile 700253545), according to an Oxford Pharmascience media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top